Blue Lake Biotechnology is an intranasal vaccine company enlisting the full force of the immune system to keep people healthy, prevent serious infectious diseases, and save the lives of vulnerable populations. Leveraging our easy-to-manufacture, broadly applicable proprietary platform, we have generated a robust clinical-stage pipeline of best- in-class vaccines designed to overcome the limitations of other technologies. Our lead product candidates have demonstrated potential for high efficacy and lasting durability with few vaccine-related side effects, which may overcome vaccine fatigue to help increase vaccination rates.
We aspire to transform the healthcare landscape and create a healthier world with better vaccines that are painless, easy, and effective.
PROPRIETARY PLATFORM: Our vaccines use a proprietary PIV5 (parainfluenza virus 5) vector, into which a foreign gene from the targeted pathogen is inserted